SEC seeks Zydus to submit revised protocol for phase I trial of chikungunya vaccine: Gireesh Babu, New Delhi Friday, October 3, 2025, 08:00 Hrs [IST] The Subject Expert Committee ...

Long-term follow-up in such diseases as psoriasis and atopic dermatitis are reinforcing the empiric impression that a ‘super ...

"Nanobiotix’s HNSCC hopeful wins in Phase I oesophageal cancer trial" was originally created and published by Clinical Trials ...

This paper would be of interest to researchers studying cognitive control and adaptive behavior, if the concerns raised in the reviews can be addressed satisfactorily. Understanding how task knowledge ...

Get insights on the upcoming HOPE 3 phase 3 trial, key endpoints, and investment risks for CAPR. Learn what to watch in ...

Pep Guardiola was has hit back with a snappy response for one journalist questioning him over Manchester City conceding after ...

Merck has shared positive results from the Phase II IDeate-Lung01 trial (NCT05280470) evaluating ifinatamab deruxtecan (I-DXd) in patients with previously treated extensive-stage small cell lung ...

CAN-2409 improved disease-free survival in patients with intermediate-to-high-risk, localized prostate cancer compared to placebo in patients treated with either conventional or moderate ...

When disasters strike the U.S. Army Corps of Engineers Nashville District’s Emergency Management team stands ready—partnering ...

In the initial phase, QRVs will be staffed by existing DFS personnel, while in the second phase it is planned to outsource manpower, the statement said.

VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (HS) and the first Phase 3 program ...

VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (HS) and the first Phase 3 ...